Xue James Qun - Net Worth and Insider Trading
Xue James Qun Net Worth
The estimated net worth of Xue James Qun is at least $19 Million dollars as of 2024-09-28. Xue James Qun is the 2101 Beneficial owner of Canbridge Pharmaceuticals Inc and owns about 56,199,581 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) stock worth over $19 Million. Details can be seen in Xue James Qun's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Xue James Qun has not made any transactions after 2024-06-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Xue James Qun
Xue James Qun Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Xue James Qun owns 1 companies in total, including Canbridge Pharmaceuticals Inc (HKSE:01228) .
Click here to see the complete history of Xue James Qun’s form 4 insider trades.
Insider Ownership Summary of Xue James Qun
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01228 | Canbridge Pharmaceuticals Inc | 2024-06-14 | 2101 Beneficial owner |
Xue James Qun Latest Holdings Summary
Xue James Qun currently owns a total of 1 stock. Xue James Qun owns 56,199,581 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) as of June 12, 2024, with a value of $19 Million.
Latest Holdings of Xue James Qun
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01228 | Canbridge Pharmaceuticals Inc | 2024-06-12 | 56,199,581 | 0.34 | 18,826,860 |
Holding Weightings of Xue James Qun
Xue James Qun Form 4 Trading Tracker
According to the SEC Form 4 filings, Xue James Qun has made a total of 4 transactions in Canbridge Pharmaceuticals Inc (HKSE:01228) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Canbridge Pharmaceuticals Inc is the sale of 4,055 shares on June 12, 2024, which brought Xue James Qun around $0.
Insider Trading History of Xue James Qun
- 1
Xue James Qun Trading Performance
Xue James Qun Ownership Network
Xue James Qun Owned Company Details
What does Canbridge Pharmaceuticals Inc do?
Who are the key executives at Canbridge Pharmaceuticals Inc?
Xue James Qun is the 2101 Beneficial owner of Canbridge Pharmaceuticals Inc. Other key executives at Canbridge Pharmaceuticals Inc include 2102 Investment manager Athos Capital Limited , 2201 Interest of corporation controlled by you Moskey Matthew Love , and 2201 Interest of corporation controlled by you Schulte-Hillen Friedrich Bela .
Canbridge Pharmaceuticals Inc (HKSE:01228) Insider Trades Summary
Over the past 18 months, Xue James Qun made 2 insider transaction in Canbridge Pharmaceuticals Inc (HKSE:01228) with a net sale of 0. Other recent insider transactions involving Canbridge Pharmaceuticals Inc (HKSE:01228) include a net purchase of 52,665,590 shares made by Schulte-Hillen Friedrich Bela , a net purchase of 52,665,590 shares made by Moskey Matthew Love , and a net purchase of 52,665,590 shares made by Athos Capital Limited .
In summary, during the past 3 months, insiders sold 0 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) were sold and 198,537,986 shares were bought by its insiders, resulting in a net purchase of 198,537,986 shares.
Canbridge Pharmaceuticals Inc (HKSE:01228)'s detailed insider trading history can be found in Insider Trading Tracker table.
Canbridge Pharmaceuticals Inc Insider Transactions
Xue James Qun Mailing Address
Above is the net worth, insider trading, and ownership report for Xue James Qun. Currently GuruFocus does not have mailing address information for Xue James Qun.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
